About 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide
2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide (PubChem CID 135472841) has the molecular formula C10H13N5O2S
and a molecular weight of 267.31 g/mol. Its IUPAC name is 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide.
Analyze 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide?
The IUPAC name of 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide (CID 135472841) is 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide.
What is the SMILES notation for 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide?
The canonical SMILES for 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide is CCCNC(=O)CSc1nc2[nH]ncc2c(=O)[nH]1.
What is the InChIKey of 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide?
The InChIKey is ZTFNBUUBOVFKKM-UHFFFAOYSA-N. The full InChI is InChI=1S/C10H13N5O2S/c1-2-3-11-7(16)5-18-10-13-8-6(4-12-15-8)9(17)14-10/h4H,2-3,5H2,1H3,(H,11,16)(H2,12,13,14,15,17).
What are the key properties of 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide?
2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide has a molecular weight of 267.31 g/mol, XLogP of 0.26, 5 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(4-oxo-1,5-dihydropyrazolo[5,4-d]pyrimidin-6-yl)sulfanyl]-N-propylacetamide is sourced from PubChem (CID 135472841), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).